← Back to Search

Ancillary-Correlative (cytology specimen collection) for Ganglioneuroblastoma

N/A
Recruiting
Led By Michael Hogarty
Research Sponsored by Children's Oncology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights

Summary

This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

Eligible Conditions
  • Ganglioneuroblastoma
  • Neuroblastoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Database of the known biologic prognostic factors for patients on therapeutic studies
Expression pattern of neurotrophin-related genes in diagnostic neuroblastoma tumors
Factors currently used for risk-group assignment (DNA content, MYCN copy number, and tumor histology)
+3 more
Secondary outcome measures
Incidence of OMA
Incidence of spinal cord compression
MYCN status per blood
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ancillary-Correlative (cytology specimen collection)Experimental Treatment2 Interventions
Patients undergo collection of blood, tissue, and bone marrow samples for analysis via RT-PCR, quantitative PCR, flow cytometry, and FISH.

Find a Location

Who is running the clinical trial?

Children's Oncology GroupLead Sponsor
457 Previous Clinical Trials
229,830 Total Patients Enrolled
5 Trials studying Ganglioneuroblastoma
1,635 Patients Enrolled for Ganglioneuroblastoma
National Cancer Institute (NCI)NIH
13,841 Previous Clinical Trials
40,992,815 Total Patients Enrolled
11 Trials studying Ganglioneuroblastoma
2,354 Patients Enrolled for Ganglioneuroblastoma
Michael HogartyPrincipal InvestigatorChildren's Oncology Group
~6667 spots leftby Jan 2100
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top